Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease: Pro-CAA position statement

Neurobiology of Aging

Volumn 25, Issue 5, 2004, Pages 589-597

  Nicoll, James A R ^a   Yamada, Masahito ^b   Frackowiak, Janusz ^c   Mazur Kolecka, Bozena ^c   Weller, Roy O ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b KANAZAWA UNIVERSITY   (Japan)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer's disease; Amyloid protein; Apolipoprotein E; Cerebral amyloid angiopathy; Cerebrovascular disease; Lipid transport; Pericytes; Perivascular drainage; Vascular smooth muscle cells

Indexed keywords

AMYLOID A PROTEIN; AMYLOID BETA PROTEIN; LIPID;

AGING; ALZHEIMER DISEASE; BIOACCUMULATION; BRAIN DEGENERATION; BRAIN LEVEL; CEREBROVASCULAR DISEASE; CONFERENCE PAPER; DEMENTIA; EXTRACELLULAR FLUID; GENETIC RISK; HUMAN; LIPID TRANSPORT; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PARENCHYMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN INDUCTION; RISK FACTOR; SMOOTH MUSCLE FIBER; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BLOOD VESSELS; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEUROFIBRILLARY TANGLES; RISK FACTORS; SENILE PLAQUES;

EID: 2542455536     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2004.02.003     Document Type: Conference Paper

References (61)

1. Bacskai B.J., Kajdasz S.T., Christie R.H., Carter C., Games D., Seubert P., et al. Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat. Med. 7(3):2001;369-372
2. Bading J.R., Yamada S., Mackic J.B., Kirkman L., Miller C., Calero M., et al. Brain clearance of Alzheimer's amyloid-beta40 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy. J. Drug Target. 10(4):2002;359-368
3. Beach T.G., Potter P.E., Kuo Y.M., Emmerling M.R., Durham R.A., Webster S.D., et al. Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta deposition. Neurosci. Lett. 283(1):2000;9-12
4. Calhoun M.E., Burgermeister P., Phinney A.L., Stalder M., Tolnay M., Wiederhold K.H., et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc. Natl. Acad. Sci. U.S.A. 96(24):1999;14088-14093
5. Cserr H.F., Harling-Berg C.J., Knopf P.M. Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol. 2(4):1992;269-276
6. D'Andrea M.R., Nagele R.G., Wang H.Y., Peterson P.A., Lee D.H. Evidence, that neurons accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology. 38:2001;120-134
7. Duvernoy H.M., Delon S., Vannson J.L. Cortical blood vessels of the human brain. Brain Res. Bull. 7:1981;519-579
8. Frackowiak J., Mazur-Kolecka B., Carroll R.T., Chauhan A., Wisniewski H.M. Factors secreted by activated microglia and monocytes reduce amyloidogenesis in vascular smooth muscle cells. Neuroreport. 8:1997;2259-2263
9. Frackowiak J, Mazur-Kolecka B, Wegiel J, Kim KS, Wisniewski HM. Culture of canine vascular myocytes as a model to study production and accumulation of β-protein by cells involved in amyloidogenesis. In: Iqbal K, Mortimer JA, Winblad B, Wisniewski HM, editors. Research advances in Alzheimer's disease and related disorders. Chi chester, England: John Wiley & Sons Ltd.; 1995. p. 747-54.
10. Frackowiak J., Mazur-Kolecka B., Wisniewski H.M., Potempska A., Carroll R.T., Emmerling M.R., et al. Secretion and accumulation of β-protein by cultured vascular smooth muscle cells from old and young dogs. Brain Res. 676:1995;225-230
11. Frackowiak J, Mazur-Kolecka B, Potempska A, Sukontasup T, Kowal D. Vascular myocytes cultured from APP-Swedish transgenic mouse deposit Aβ in lysosomes. In: Korczyn AD, Monduzzi E, editors. 2nd International Congress on Vascular Dementia; 2002. p. 177-81.
12. Frackowiak J., Miller D.L., Potempska A., Sukontasup T., Mazur-Kolecka B. Secretion and accumulation of Aβ by brain vascular smooth muscle cells from AβPP-Swedish transgenic mice. J. Neuropathol. Exp. Neurol. 62:2003;685-696
13. Frackowiak J., Zoltowska A., Wisniewski H.M. Non-fibrillar β-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J. Neuropathol. Exp. Neurol. 53:1994;637-645
14. Graham D.I., Hume Adams J., Nicoll J.A.R., Maxwell W.L., Gennarelli T.M. The nature, distribution and causes of traumatic brain injury. Brain Pathol. 5:1995;397-406
15. Greenberg S.M., Rebeck G.W., Vonsattel J.P., Gomez-Isla T., Hyman B.T. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 38(2):1995;254-259
16. Kalimo H, Kaste M, Haltia M. Vascular diseases. In: Graham DI, Lantos PL, editors. Greenfield's Neuropathology, 7th ed. London: Arnold; 2002.
17. Kuo Y.M., Beach T.G., Sue L.I., Scott S., Layne K.J., Kokjohn T.A., et al. The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease. Mol. Med. 7(9):2001;609-618
18. LaFerla F.M., Troncoso J.C., Strickland D.K., Kawas C.H., Jay G. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular A-beta stabilization. J. Clin. Invest. 100:1997;310-320
19. Mazur-Kolecka B., Frackowiak J., Kowal D., Krzeslowska J., Dickson D. Oxidative protein damage in cells engaged in β-amyloidosis is related to apoE genotype. Neuroreport. 13:2002;465-468
20. Mazur-Kolecka B., Frackowiak J., Le Vine H., Haske T., Evans L., Sukontasup T., et al. TGF-beta1 enhances formation of cellular A beta/apoE deposits in vascular myocytes. Neurobiol. Aging. 24:2003;355-364
21. Mazur-Kolecka B., Frackowiak J., Le Vine H. III, Haske T., Wisniewski H.M. Factors produced by activated macrophages reduce accumulation of Alzheimer's β-amyloid protein in vascular smooth muscle cells. Brain Res. 760:1997;255-260
22. Mazur-Kolecka B., Frackowiak J., Carroll R.T., Wisniewski H.M. Accumulation of Alzheimer amyloid-beta peptide in cultured myocytes is enhanced by serum and reduced by cerebrospinal fluid. J. Neuropathol. Exp. Neurol. 56(3):1997;263-272
23. Mazur-Kolecka B., Frackowiak J., Wisniewski H.M. Apolipoproteins E3 and E4 induce, and transthyretin prevents accumulation of the Alzheimer's β-amyloid peptide in cultured vascular smooth muscle cells. Brain Res. 698:1995;217-222
24. McCarron M.O., Nicoll J.A., Stewart J., Cole G.M., Yang F., Ironside J.W., et al. Amyloid beta-protein length and cerebral amyloid angiopathy-related haemorrhage. Neuroreport. 11(5):2000;937-940
25. McLean C.A., Cherny R.A., Fraser F.W., Fuller S.J., Smith M.J., Beyreuther K., et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46:1999;860-866
26. Meyer-Luehmann M., Stalder M., Herzig M.C., Kaeser S.A., Kohler E., Pfeifer M., et al. Extracellular amyloid formation and associated pathology in neural grafts. Nat. Neurosci. 6(4):2003;370-377
27. Miyakawa T., Katsuragi S., Watanabe K., Shimoji A., Ikeuchi Y. Ultrastructural studies of amyloid fibrils and senile plaques in human brain. Acta Neuropathol. (Berl). 70:1986;202-208
28. Neuropathology Group. Medical research council cognitive function and aging study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology group of the medical research council cognitive function and ageing study (MRC CFAS). Lancet 2001;357(9251): 169-75.
29. Nicoll J.A., Burnett C., Love S., Graham D.I., Dewar D., Ironside J.W., et al. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann. Neurol. 41(6):1997;716-721
30. Nicoll J.A., Weller R.O. A new role for astrocytes: β-amyloid homeostasis and degradation. Trends Mol. Med. 9(7):2003;281-282
31. Nicoll J.A., Wilkinson D., Holmes C., Steart P., Markham H., Weller R.O. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat. Med. 9(4):2003;448-452
32. Nicoll J.A.R., Roberts G.W., Graham D.I. Apolipoprotein E ε4 allele is associated with deposition of β-amyloid protein following head injury. Nat. Med. 1:1995;135-137
33. Perry E.K., Kilford L., Lees A.J., Burn D.J., Perry R.H. Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. Ann. Neurol. 54(2):2003;235-238
34. Poirier J. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Trends Mol. Med. 9(3):2003;94-101
35. Premkumar D.R., Cohen D.L., Hedera P., Friedland R.P., Kalaria R.N. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 148(6):1996;2083-2095
36. Preston S.D., Steart P.V., Wilkinson A., Nicoll J.A., Weller R.O. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol. Appl. Neurobiol. 29(2):2003;106-117
37. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400(6740):1999;173-177
38. Shibata M., Yamada S., Kumar S.R., Calero M., Bading J., Frangione B., et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106(12):2000;1489-1499
39. Skoog I., Gustafson D. Hypertension and related factors in the etiology of Alzheimer's disease. Ann. N Y Acad. Sci. 977:2002;29-36
40. Taubes G. Insulin insults may spur Alzheimer's disease. Science. 301(5629):20030;40-41
41. Van Dorpe J., Smeijers L., Dewachter I., Nuyens D., Spittaels K., Van Den Haute C., et al. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am. J. Pathol. 157(4):2000;1283-1298
42. Van Nostrand W.E., Melchior J.P. Disruption of pathologic amyloid beta-protein fibril assembly on the surface of cultured cerebrovascular smooth muscle cells. Amyloid. 8:2001;20-27
43. Verbeek M.M., Otte-Holler I., Wesseling P., Ruiter D.J., de Waal R.M.W. Induction of α-smooth muscle actin expression in cultuires human brain pericytes by Transforming Growth Factor-β1. Am. J. Pathol. 144:1994;372-382
44. Vidal R., Calero M., Revesz T., Plant G., Ghiso J., Frangione B. Sequence, genomic structure and tissue expression of Human BRI3, a member of the BRI gene family. Gene. 266(1/2):2001;95-102
45. Vinters H.V., Wang Z.Z., Secor D.L. Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol. 6:1996;179-195
46. Wegiel J., Wisniewski H.M., Dziewiatkowski J., Tarnawski M., Nowakowski J., Dziewiatkowska A., et al. The origin of amyloid in cerebral vessels of aged dogs. Brain Res. 705:1995;225-234
47. Weller R.O., Massey A., Kuo Y.M., Roher A.E. Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease. Ann. N Y Acad. Sci. 903:2000;110-117
48. Weller R.O., Massey A., Newman T.A., Hutchings M., Kuo Y.M., Roher A.E. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am. J. Pathol. 153(3):1998;725-733
49. Weller R.O., Yow H.Y., Preston S.D., Mazanti I., Nicoll J.A. Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease. Ann. N Y Acad. Sci. 977:2002;162-168
50. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., Delon M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215(4537):1982;1237-1239
51. Wisniewski H.M., Frackowiak J., Zoltowska A., Kim K.S. Vascular β-amyloid in Alzheimer disease angiopathy is produced by proliferating and degenerating smooth muscle cells. Amyloid. 1:1994;8-16
52. Wisniewski H.M., Frackowiak J., Mazur-Kolecka B. In vitro production of β- protein in smooth muscle cells isolated from amyloid angiopathy-affected vessels. Neurosci. Lett. 183:1995;120-123
53. Wisniewski H.M., Wegiel J., Vorbrodt A.W., Mazur-Kolecka B., Frackowiak J. Role of perivascular cells and myocytes in vascular amyloidosis. Ann. N Y Acad. Sci. 903:2000;6-18
54. Wisniewski H.M., Wegiel J. β-Amyloid formation by myocytes of leptomeningeal vessels. Acta. Neuropathol. (Berl.). 87:1994;233-241
55. Wyss-Coray T., Lin C., Sanan D.A., Mucke L., Masliah E. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am. J. Pathol. 156(1):2000;139-150
56. Yamada M., Itoh Y., Suematsu N., Otomo E., Matsushita M. Vascular variant of Alzheimer's disease characterized by severe plaque-like beta protein angiopathy. Dement. Geriatr. Cogn. Disord. 8(3):1997;163-168
57. Yamada M., Sodeyama N., Itoh Y., Suematsu N., Otomo E., Matsushita M., et al. Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly. Stroke. 28(11):1997;2219-2221
58. Yamada M., Sodeyama N., Itoh Y., Suematsu N., Otomo E., Matsushita M., et al. Association of alpha1-antichymotrypsin polymorphism with cerebral amyloid angiopathy. Ann. Neurol. 44(1):1998;129-131
59. Yamada M., Sodeyama N., Itoh Y., Takahashi A., Otomo E., Matsushita M., et al. Association of neprilysin polymorphism with cerebral amyloid angiopathy. J. Neurol. Neurosurg. Psychiatry. 74(6):2003;749-751
60. Yamada M. Risk factors for cerebral amyloid angiopathy in the elderly. Ann. N Y Acad. Sci. 977:2002;37-44
61. Yow H.Y., Weller R.O. A role for cerebrovascular disease in determining the pattern of beta amyloid deposition in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 28:2002;149